| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 28 Sep 2026 | 3 Sep 2026 |
| Outcome of the Meeting of the Board of Directors held on September 03, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thirty Third Annual Report for the Financial Year 2025-2026 of Kimia Biosciences Limited (As per BSE Announcement dated on: 04.09.2026). Submission of proceedings of the 33rd Annual General Meeting pursuant to regulations 30 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 (As per BSE announcement dated on : 28.09.2026). Declaration of Results of Remote E voting and Evoting at AGM held on 28.09.2026 along with Scruitiniser Report provided by Maya Sharma and Associates Company secretaries under regulation 44 of LODR Regulation. (As per BSE announcement dated on : 29.09.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.